Paper Details

  1. Home
  2. Paper Details

Use of Intraventricular Medications in Critically Ill Patients: A Systematic Review.

Author: BartholColleen A, ErdmanMichael J, HallerJ Tyler, MarreseAlexa R, SmallClay E

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This review discusses the administration, dosing, monitoring, and adverse effects of intraventricular (IVT) medication usage in the neurologic intensive care unit. Several medications have shown promise for critically ill patients, including amphotericin B, aminoglycosides, colistimethate, daptomycin, quinupristin/dalfopristin, vancomycin, alteplase, and nicardipine. While one randomized, placebo-controlled trial of alteplase showed decreased mortality, more research is needed.
Paper Details　
Original Abstract of the Article :
New evidence and increased use of intracranial devices have increased the frequency of intraventricular (IVT) medication administration in the neurologic intensive care unit. Significant benefits and risks are associated with administration of medications directly into the central nervous system. Th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/32084060

データ提供：米国国立医学図書館（NLM）

Intraventricular Medications: A Review of Benefits and Risks

This study reviews the use of intraventricular (IVT) medication administration in critically ill patients, particularly in neurologic intensive care units. The researchers provide a comprehensive overview of the benefits and risks associated with administering medications directly into the central nervous system. The study highlights the growing use of IVT medications, particularly for conditions like meningitis, encephalitis, and stroke, and provides valuable information for clinicians on medication administration, dosing, monitoring, and adverse effects.

IVT Medications: Navigating a Complex Path

This study offers valuable insights into the use of intraventricular medications in critically ill patients, highlighting the need for careful consideration of both the potential benefits and risks associated with this approach. The study emphasizes the importance of implementing protocols to ensure optimal patient outcomes and minimize adverse effects.

Navigating the Central Nervous System: A Camel's Perspective on Treatment

As a camel, I know that the desert's terrain can be unpredictable. Treating critical illnesses, much like navigating a desert, requires careful consideration and a precise approach. This study underscores the importance of understanding the nuances of IVT medication administration, weighing the benefits against the potential risks to ensure the best possible outcomes for patients.

Dr.Camel's Conclusion

This study provides a valuable review of the use of intraventricular medications in critically ill patients, highlighting the benefits, risks, and important considerations for clinicians. It emphasizes the need for careful administration, monitoring, and management of potential adverse effects to ensure optimal patient outcomes.
Date :
  1. Date Completed 2020-10-01
  2. Date Revised 2021-01-21
Further Info :

Pubmed ID

32084060

DOI: Digital Object Identifier

00002727-202004000-00005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.